Samsung Biologics vs SK pharmteco: CDMO Comparison
How does Samsung Biologics compare to SK pharmteco for ADC manufacturing?
Side-by-side comparison of Samsung Biologics and SK pharmteco on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Composite Signal Score: SK pharmteco 80/100 vs Samsung Biologics 62/100 — a 18-point gap reflecting the combined quality, capacity and financial signal.
On a 13-modality CDMO landscape, both Samsung Biologics and SK pharmteco qualify as ADC manufacturers; SK pharmteco carries the higher composite Signal Score for ADC programs in this comparison.
What to evaluate for ADC programs
Both Samsung Biologics and SK pharmteco qualify as ADC CDMOs. When choosing between them for ADC programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
HPAPI containment
Look for OEB-5 (sub-microgram occupational exposure band) suites for handling cytotoxic payloads end-to-end. Containment maturity is the floor for credible commercial ADC work.
Linker-payload chemistry on file
Match the CDMO's payload + linker experience to your program. MMAE / vc-MMAE is the most common; PBDs, calicheamicin, Dxd-class topoI inhibitors, and TLR agonists each carry distinct handling and analytical demands.
Commercial bioconjugation track record
Has the CDMO conjugated a commercially-approved ADC? Track record on Polivy, Padcev, Trodelvy, Enhertu, Tivdak, Elahere, Adcetris, Mylotarg, Besponsa, Lumoxiti, Blenrep, etc. is a strong qualifying signal.
Integrated DS + DP
Bioconjugation produces ADC drug substance; you'll also need sterile fill-finish for drug product. Confirm whether the CDMO covers both or partners — both routes work, but integrated is faster on transfer.
Frequently asked: Samsung Biologics vs SK pharmteco
How does Samsung Biologics compare to SK pharmteco for ADC manufacturing?
On CDMO Signal's composite Signal Score, Samsung Biologics is 62/100 and SK pharmteco is 80/100. Both are tracked in the CDMO Signal directory as ADC CDMOs. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which is better for ADC manufacturing — Samsung Biologics or SK pharmteco?
Both Samsung Biologics and SK pharmteco are tagged as ADC CDMOs in our directory, so both are credible options for ADC programs. The most important differentiator for ADC selection is typically hpapi containment: Look for OEB-5 (sub-microgram occupational exposure band) suites for handling cytotoxic payloads end-to-end. Containment maturity is the floor for credible commercial ADC work. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
Samsung Biologics carries a Signal Score of 62/100 and SK pharmteco carries 80/100 — a meaningful lead for SK pharmteco. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →